reverSASP ^None

reverSASP Therapeutics develops drugs that target senescent cells to treat aging-related diseases. The company's focus is on the Senescence-associated secretory phenotype (SASP) as a drug target, and it has a strong understanding of the underlying biology of aging-related diseases.